Evaluation of the potential carcinogenicity of azaserine (115-02-6). Final report

Technical Report · Wed Jun 01 00:00:00 EDT 1988

OSTI ID:6478094

Azaserine is a probable human carcinogen, classified as weight-of-evidence Group B2 under the EPA Guidelines for Carcinogen Risk Assessment. Evidence on potential carcinogenicity from animal studies is Sufficient, and the evidence from human studies is No Data. The potency factor (F) for azaserine is estimated to be 169 (mg/kg/day)(-1), placing it in potency group 1 according to the CAG's methodology for evaluating potential carcinogens. Combining the weight-of-evidence group and the potency group, azaserine is assigned a HIGH hazard ranking for the purposes of RQ adjustment.

• Research Organization: Syracuse Research Corp., NY (United States)
• OSTI ID: 6478094
• Report Number(s): PB-93-184901/XAB; CNN: EPA-68-03-3112; EPA-68-03-3182
• Country of Publication: United States
• Language: English

Related Subjects

29 ENERGY PLANNING, POLICY, AND ECONOMY
290300* -- Energy Planning & Policy-- Environment
Health
& Safety
ANIMALS
CARCINOGENS
DATA PROCESSING
DOCUMENT TYPES
HAZARDOUS MATERIALS
HUMAN POPULATIONS
LABORATORY ANIMALS
MATERIALS
NATIONAL ORGANIZATIONS
POPULATIONS
PROCESSING
PUBLIC HEALTH
REGULATORY GUIDES
RISK ASSESSMENT
SAFETY
TASK SCHEDULING
TOXIC MATERIALS
US EPA
US ORGANIZATIONS
WEIGHT